In a groundbreaking plant-based immunotherapy development in the field of oncology, a start-up pharmaceutical firm in Thailand, Baiya Phytopharm, proclaimed the successful creation of anti-cancer antibodies derived from tobacco plants. The company announced these results in the wake of effectively conducting experiential trials on lab animals.
Operating under the umbrella of Chulalongkorn University, Baiya Phytopharm is recognised for its accomplishments in developing Baiya Sars-CoV-2 Vax, a plant-based Covid-19 vaccine. Nevertheless, it has now achieved a novel landmark in the sphere of plant-based immunotherapy.
The biopharmaceutical research initiated by the company, focusing on cancer treatment via plant-based immunotherapy, was honoured with the Research of the Year 2023 title by the National Research Council of Thailand.
…
